Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
The EuroNanoMed ERA-NET serves as a platform for European funding agencies and ministries, to develop joint activities and programmes in order to coordinate high quality research in Nanomedicine across national borders. The aims of the call are: |
Característiques principals
Project proposals will address multidisciplinary and translational research. The project proposals must cover at least one of the following areas that are equal in relevance for this call: a) Regenerative medicine b) Diagnostics c) Targeted delivery systems |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00. Carol Barnwell: cbarnwell@imim.es Ext.: 1670 Marta López: mlopez4@imim.es Ext.: 1576 |
Convocatòria (URL)
http://www.euronanomed.net/joint-calls/7th-joint-call-2016/ |
Informació addicional
Only transnational projects will be funded. Each proposal must involve a minimum of three research groups eligible for the funding organisations participating in the EuroNanoMed II 7th Joint Transnational Call. Moreover, these eligible research groups must come from at least three different countries. No more than two eligible research groups from the same country participating in the call will be accepted Research groups not eligible to be funded (e.g. from non-funding countries or not fundable according to national/regional regulations of the participating funding countries) may participate in transnational projects if they are able to secure their own funding. Such partners should state in advance the source of funding for their part in the project and are considered as full project partners. However, their country will not be taken into account to meet the above-mentioned criterion. In addition, the majority of research groups in a consortium and the coordinator must be eligible to be funded by EuroNanoMed II participating countries/regions (see Annex I). In any case, the maximum number of participants in a project consortium is seven (including eligible for funding and non-eligible for funding research groups). Each application should include partners from at least two of the following categories: academia, clinical/public health, private sector (industry/SME). Please note that if a partner is found to be non-eligible by one of the funding organisations after the formal check, the entire proposal could be rejected without further review. Whilst applications will be submitted jointly by groups from several countries, individual groups will be funded by the individual EuroNanoMed II funding organization respective of the country/region from which applicants have applied. Please see the Guidelines for eligibility conditions relating to Spanish groups. |
Informació addicional
Aplicatiu web: https://www.pt-it.de/ptoutline/application/euronanomed2016 |
Dotació
Per a participants espanyols: |
Durada
Fins a 3 anys, depenent de les condicions particulars de cada país. |
Incompatibilitats
Els investigadors espanyols només podran estar presents en una única sol·licitud. |
AVÍS IMPORTANT
Applicants are strongly advised to contact their relevant funding organisation contact person before submitting an application; please note that for some countries/regions it might be mandatory. |
Arxius
Arxiu |
---|
Proposal form |
Call text |
Guidelines ***NEW*** |